HLA-DRBeta1, circulating Th1/Th2 cytokines and immunological homunculus in coronary atherosclerosis

Amrollah Mostafazadeh1, Mehrdad Saravi, Haleh Akhavan Niaki

  • 1Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran. amrolah65@yahoo.com

Insights

This study suggests that the anti-inflammatory cytokine Interleukin-10 (IL-10) and the HLA-DR16 allele may protect against coronary atherosclerosis by potentially counteracting LDL-cholesterol effects.

Area of Science:

  • Immunogenetics
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Coronary atherosclerotic disease (CAD) is a leading global health concern.
  • The role of human leukocyte antigen (HLA) alleles and cytokine profiles in CAD pathogenesis requires further investigation.

Purpose of the Study:

  • To explore the association between Human Leukocyte Antigen (HLA)-DRB1 alleles and circulating Th1/Th2 cytokine levels in patients with coronary atherosclerosis.
  • To investigate the relationship between lipid profiles and these immunological markers in different CAD patient groups.

Main Methods:

  • Serum samples from 31 unstable angina, 27 chronic stable angina patients, and 24 controls were analyzed for Th1/Th2 cytokines (IL-10, IFN-gamma, IL-4) using ELISA.
  • HLA-DRB1 alleles were typed in 24 subjects using SSP-PCR.
  • Lipid profiles were determined using standard clinical laboratory methods.

Main Results:

  • Normal controls exhibited significantly higher mean serum IL-10 levels compared to unstable angina (p<0.028) and chronic stable angina groups.
  • No significant differences were observed in serum levels of IFN-gamma and IL-4 among the groups.
  • HLA-DR16 was present in 33.33% of normal controls but absent in all CAD patients.

Conclusions:

  • Elevated IL-10 and the presence of HLA-DR16 in normal controls suggest a potential protective role against coronary atherosclerosis.
  • This may involve dampening the atherogenic effects of LDL-cholesterol, possibly mediated by HDL-cholesterol and anti-inflammatory pathways.